Antibiotic Therapy in Infectious Diseases
A section of Antibiotics (ISSN 2079-6382).
Section Information
Antibiotics play a vital role in modern medicine. Their discovery and use after World War II significantly increased human life expectancy. They are used primarily to treat bacterial infections, but also sometimes used to prevent them, mainly in the surgical setting.
From 1940 to 1990, the discovery of new antibiotics was very dynamic, making it possible to control most bacterial infectious diseases in developed countries. However, antibiotics should only be prescribed in cases of proven or strongly suspected bacterial infection, because their overuse has led to the emergence of resistant bacteria, making treatments less effective. Thus, bacterial resistance appeared quickly after the introduction of each new antibiotic, driving continuous innovation.
From the 1990s onwards, the discovery of new molecules slowed down, while resistance increased, first affecting hospitals. Since the 2000s, very few new antibiotics have been introduced, while the effectiveness of some older treatments is decreasing due to growing resistance resulting from bacterial adaptation. Major pharmaceutical companies are turning away from antibiotic research, which is considered unprofitable compared to other fields such as oncology. New antibiotics, when developed, are reserved for last-resort use to limit the development of resistance, limiting their use and therefore profitability.
The aim of this Section is to improve the use of antibiotics in order to limit bacterial resistance and preserve their role in the future.
The Section's main topics include the following:
- Antibiotic resistance: resistance mechanisms, their impact on drug efficacy, and strategies to limit this phenomenon.
- Studies on new therapeutic strategies: new molecules or optimization of existing treatments and antibiotic combinations.
- Antibiotic stewardship: strategies to avoid overuse and inappropriate use, and promote the optimal duration of use.
- Alternatives to antibiotics: phage therapy, vaccination to prevent bacterial infections, and other innovative approaches.
- Epidemiologic studies on antibiotic use.
Promoting optimal strategies for antibiotic prescription and limiting the impact of antibiotic resistance on public health remain the Section’s main goals.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- The Interventions to Prevent and Reduce Healthcare-Associated Infection (Deadline: 30 November 2025)
- A Themed Issue in Honor of Dr. Lynne V. McFarland—Clostridioides difficile Infection and Impact of Antibiotics on the Intestinal Microbiome (Deadline: 30 November 2025)
- Resistance and Evolving Biology in Mycobacteria: Multidisciplinarity as a Contemporary Approach (Deadline: 30 November 2025)
- Hospital-Associated Infectious Diseases and Antibiotic Therapy (Deadline: 31 December 2025)
- Managing Staphylococcus spp. Infections: Current Practices and Future Directions (Deadline: 31 December 2025)
- Innovative Treatments for Hospital-Acquired Multidrug-Resistant Bacterial Infections (Deadline: 31 December 2025)
- Clostridioides difficile Infection, 3rd Edition (Deadline: 31 December 2025)
- Preventing Antimicrobial Resistance in Hospitals: Infection Control and Antibiotic Use (Deadline: 31 December 2025)
- Carbapenem-Resistant Acinetobacter baumannii: From Molecular Mechanisms to Clinical Practice (Deadline: 31 December 2025)
- Therapy of Infectious Diseases Among Children and Adults: The Role of Antibiotics in Daily Practice (Deadline: 31 December 2025)
- New Insights into Prevention, Diagnosis, and Treatment of Neonatal Sepsis and Short- and Long-Term Outcomes (Deadline: 20 January 2026)
- Multidrug-Resistant Gram-Negative Bacteria Infections: Current Epidemiology, Prognosis and Treatment Options (Deadline: 31 January 2026)
- Bacterial Infections and Global Health: The Escalating Threat of Antibiotic Resistance (Deadline: 31 January 2026)
- Diagnostics and Antibiotic Therapy in Bone and Joint Infections (Deadline: 31 January 2026)
- Dermatological Infections and Antibiotic Treatment (Deadline: 31 January 2026)
- Single-Stage Management of Musculo-Skeletal Infections: Local Antibacterial Protection, Antibiotics, and Surgical Treatments (Deadline: 31 January 2026)
- Pharmacologic Management of MDR Respiratory and Bacteraemic Infections (Deadline: 28 February 2026)
- Antimicrobial Stewardship and Infection Prevention in Intensive Care Unit (Deadline: 28 February 2026)
- Progress and Challenges in the Antibiotic Treatment of Infections (Deadline: 28 February 2026)
- Feature Papers in Therapy of Diabetic Foot Infections (Deadline: 28 February 2026)
- Urinary Tract Infections: Diagnosis, Etiology, Antibiotic Treatment, and Current Trends in Antimicrobial Resistance (Deadline: 28 February 2026)
- Pioneering the Microbiome—Infections, Inflammation, Inflammatory Bowel Disease and the Role of Antibiotic Therapy (Deadline: 28 February 2026)
- New Advances in Antibiotic Therapy in the Gastroenterology Field (Deadline: 28 February 2026)
- Antibiotic Therapy in Respiratory Tract Infections (RTIs) (Deadline: 2 March 2026)
- Antibiotic Resistance in Hospital-Acquired Infections (Deadline: 20 March 2026)
- Hospital-Acquired Infections, Multidrug Resistant (MDR) Bacteria, AI, and Alternative Approaches to Antibiotic Therapy (Deadline: 20 March 2026)
- Optimizing Empirical Antibiotic Therapy in Critical Care: Innovations in Diagnostics, Digitalization, and Stewardship (Deadline: 31 March 2026)
- Periodontal Bacteria and Periodontitis: Infections and Therapy (Deadline: 31 March 2026)
- Advances in Infective Endocarditis Research: From Bench to Bedside (Deadline: 31 March 2026)
- Antibiotic Choices for Pediatric Infections (Deadline: 1 April 2026)
- Antimicrobial Resistance, Epidemiology, Clinical Impact and Molecular Characterization of Multidrug-Resistant ESKAPEE Pathogens (Deadline: 30 April 2026)
- Antimicrobial Treatment Challenges in Gastroenterology and Malignancy Associated Infections: Current Trends, Debates and Future Perspectives (Deadline: 30 April 2026)
- A Themed Issue in Honor of Professor Helen Giamarellou—Outstanding Contributions in the Fields of Antimicrobial Resistance and Difficult-to-Treat Resistance Pathogens (Deadline: 20 May 2026)
- Periprosthetic Joint Infection: Understanding the Epidemiology, Pathogenesis, Diagnosis and Treatment Options (Deadline: 31 May 2026)
- Optimizing Antimicrobial Therapy in NICU Settings: Strategies and Implications (Deadline: 31 May 2026)
- Antimicrobial Therapeutics for Bone and Periprosthetic Joint Infection, 2nd Edition (Deadline: 31 May 2026)
- Emerging Topics in Clostridioides difficile Infection: A One Health Problem (Deadline: 31 May 2026)
- Antimicrobial Therapy in Oral Diseases, 2nd Edition (Deadline: 15 June 2026)
- Diagnostics, Antibiotic Usage and Surgery Related Techniques in Prevention and Treatment of Prosthetic Joint and Implant Related Infections (Deadline: 30 June 2026)
- New Approaches to the Treatment and Prevention of Fungal Infections (Deadline: 30 June 2026)
- Diagnosis and Antimicrobial Therapy of Osteoarticular Infection (Deadline: 30 June 2026)
- Novel Antimicrobial Agents for Treatment of Staphylococcus aureus Infections (Deadline: 30 June 2026)
- Epidemiology and Treatment of Microbial Infections in Respiratory Diseases (Deadline: 31 October 2026)
Topical Collection
Following topical collection within this section is currently open for submissions: